L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease

[1 ] Clarunis University Center for Gastrointestinal and Liver Disorders, University Hospital of Basel, Basel, Switzerland;

[2 ] 2nd Department of Propedeutic Surgery, Athens University Medical School, Laiko General Hospital, Athens, Greece;

[3 ] 1st Department of Pathology, School of Medicine, National University of Athens, Athens, Greece